We report the generation of 2 monoclonal antibodies (MAbs), 2B12 and 3E6, s
uitable for the detection of human dUTPase in routinely processed paraffin
sections by immunohistochemistry. Using these MAbs, we observed nuclear exp
ression of dUTPase in the proliferation zones of normal colorectal mucosa a
s well as in hyperplastic polyps, Colorectal adenomas and adenocarcinomas r
evealed a wide spectrum of dUTPase expression, ranging from 5 to 63% (media
n 42%) and from 5 to 71% of tumour cells (median 42%) respectively. Non-par
ametric correlation of dUTPase expression with proliferation as determined
by a Ki-67 antigen-specific MAb revealed a significant and moderately stron
g correlation between proliferation rate and dUTPase expression in adenomas
, but not in adenocarcinomas. This finding was confirmed by double-labellin
g immunofluorescence. Unexpectedly, we found significantly lower levels of
dUTPase expression in primary colorectal carcinomas without lymphnode metas
tases at the time of surgery (Dukes A and B stages) than in Dukes C carcino
mas. While this observation requires confirmation in larger studies, it sug
gests that dUTPase expression may be a negative prognostic marker in colore
ctal carcinomas. Moreover, these reagents should prove useful in the contex
t of attempts to develop dUTPase inhibitors for cancer chemotherapy, Since
it has been demonstrated that dUTPase expression can mediate resistance to
5-fluorouracil, it is also possible that these MAbs may be helpful in ident
ifying patients with colorectal carcinomas resistant to adjuvant chemothera
py using this and related compounds. Int. J. Cancer (Pred. Oncol.) 84:614-6
17, 1999. (C) 1999 Wiley-Liss, Inc.